MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH

It is an anticancer medicinal product used to treat adults with newly diagnosed low/intermediate-risk acute promyelocytic leukemia (APL), or for patients whose disease has not responded to other therapies.

Dosage form: solution for infusion, concentrate

ATC: L01XX27

BCG-medac is used for the treatment of several types of bladder cancer, when the tumor is limited to the inner lining of the bladder (urothelium). It is also used to prevent the return of cancer.

Dosage form: suspension for intravesical use, powder and solvent

ATC: L03AX03

This medicine is used for the treatment of certain types of cancer, specifically: chronic lymphocytic leukemia (when fludarabine chemotherapy is not suitable), non-Hodgkin lymphomas (that have not responded to rituximab or have had a short response), and multiple myeloma (when high-dose chemotherapy with stem cell transplant or thalidomide- or bortezomib-based therapies are not suitable).

Dosage form: powder and concentrate for solution for infusion

ATC: L01AA09

The drug must be used exclusively via intravenous or subcutaneous administration. It must not be administered through other routes.

Dosage form: powder for solution for injection

ATC: L01XG01

It is used for the treatment of tumors of the colon, rectum, stomach, or breast. It can also be used to prevent the recurrence of colon cancer after it has been surgically removed.

Dosage form: tablets, film-coated

ATC: L01BC06

It is used for the treatment of certain types of ovarian and lung cancer (specifically, epithelial ovarian cancer and small cell lung cancer).

Dosage form: solution for infusion, concentrate

ATC: L01XA02

It is an antitumoral drug used in adults to treat various types of tumors, including brain tumors, lymphomas (Hodgkin and non-Hodgkin), gastrointestinal tract tumors, malignant melanoma, and as preparation before a stem cell transplant in certain blood diseases.

Dosage form: solution for infusion, powder and solvent for preparation

ATC: L01AD01

It is prescribed for the treatment of certain types of cancer, including advanced-stage malignant melanoma (skin cancer), Hodgkin's disease (lymphatic tissue cancer), and soft tissue sarcoma.

Dosage form: powder for preparation of injectable suspension

ATC: L01AX04

It is used to treat adult patients with active rheumatoid arthritis or active psoriatic arthritis.

Dosage form: tablets, film-coated

ATC: L04AK01

It is used in oncological therapy to alleviate the symptoms of various types of cancer (such as cancer of the intestine, stomach, breast, esophagus, cervix, lung, pancreas, or head and neck) or to prevent the recurrence of superficial bladder cancer after the removal of diseased tissue.

Dosage form: powder for intravesical solution/injectable solution

ATC: L01DC03

It is used to prevent the recurrence of superficial bladder cancer after the diseased tissue has been removed via surgery (transurethral resection).

Dosage form: solution for injection, powder and solvent for preparation of

ATC: L01DC03

This medicine is used to treat certain types of cancer, specifically malignant pleural mesothelioma (a cancer of the tissue lining the lungs) and advanced-stage lung cancer, usually in combination with another drug called cisplatin.

Dosage form: powder for concentrate for infusion solution

ATC: L01BA04

This medicinal product belongs to the group of antidotes and is used in cancer therapy for adults and children. It can be used to reduce the toxicity of substances such as methotrexate or to increase the efficacy of other anticancer drugs such as 5-fluorouracil.

Dosage form: solution for infusion

ATC: V03AF10

It is used for the treatment of adults and children suffering from acute lymphoblastic leukemia (ALL), a type of blood cancer. It works by reducing levels of asparagine, an amino acid necessary for the growth of cancer cells.

Dosage form: solution for infusion, powder for preparation

ATC: L01XX02

It is an antitumoral agent used to treat specific forms of brain cancer: in adults with newly diagnosed glioblastoma multiforme (initially in combination with radiotherapy and then alone) and in children aged 3 years and older or in adults with malignant glioma (such as glioblastoma multiforme or anaplastic astrocytoma) in the event of relapse or progression after standard therapy.

Dosage form: capsules, hard gelatin

ATC: L01AX03

It is used to prepare patients for a bone marrow transplant. The drug works by destroying bone marrow cells to allow for the implantation of new, healthy cells that can produce blood.

Dosage form: powder for concentrate for infusion solution

ATC: L01AC01

It is used to prepare adults, adolescents, and children (over one month of age) with cancer or non-cancer diseases undergoing bone marrow transplantation (hematopoietic stem cells). The drug is used to destroy bone marrow cells to allow for the engraftment of new healthy cells.

Dosage form: solution for infusion, powder for preparation

ATC: L01AB02

This medicinal product is used to treat certain types of lung cancer and certain types of breast cancer in patients over 18 years of age.

Dosage form: capsules, soft gelatin

ATC: L01CA04